In a recent study by Richard Gibbs and colleagues from Baylor College of Medicine, this new enrichment method was used for de novo sequencing and detection of structural variation involved in human genetic disease.
Mylan made an unsolicited $28.9 billion offer to buy the Irish drugmaker last week, but Perrigo’...
Anglo-Swedish drug-maker AstraZeneca PLC reported a 7 percent fall in net profit for the first...
The product is indicated for the treatment of chronic hepatitis C, a blood-borne infectious disease that affects more than 100 million people in the developing world, including approximately 12 million people in India.
Pfizer said that an experimental blood cancer drug met one of its two goals in a late-stage trial, as patients who were treated with the drug were more likely to have a complete remission.
CBRE Group, Inc. announced today that they have been hired to sell Eli Lilly’s biomanufacturing plant in Vacaville, California.
The company alerted U.S. customers Tuesday that the vaccine can lose potency and fail to adequately protect against some strains of the flu.
Kenneth C. Frazier, chairman and CEO of Merck & Co., Inc., was elected chairman of the Board of the Pharmaceutical Research and Manufacturers of America (PhRMA).
The U.S. Food and Drug Administration today approved the first generic version of Copaxone (glatiramer acetate injection), used to treat patients with relapsing forms of multiple sclerosis (MS).
The global treatment market for melanoma will expand more than fourfold in value from $1.34 billion in 2013 to reach an estimated $5.64 billion by 2023.
Innate Pharma SA has entered into a collaboration with Sanofi to apply site-specific conjugation technology to the development of new Antibody Drug Conjugate
Innocrin Pharmaceuticals is developing small-molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers.
Ventana, a member of the Roche Group, announced it has entered into a master collaboration agreement with Astellas Pharma Inc.
A lawyer for Actavis urged a U.S. appeals court on Monday to let it replace a two-pill daily regimen with a single-dose version of the drug even if it cheats generic drugmakers of profits.
Roche has acquired CAPP Medical, a genomics research company founded by Stanford University oncologists and industry veterans.
Merck is introducing Clinical Diabetes management for more than 5000 medical students in 18 medical colleges of Maharashtra University as part of Merck Capacity Advancement Program (CAP) in Asia.
Merck's agreement with AIAC is to sell the manufacturing facility in Arecibo that was under closing plans. AIAC will retain the approximately 200 Merck employees.
Baxter International Inc. announced today it is voluntarily recalling select lots of IV solutions to the hospital/user level due to the potential presence of particulate matter.
The European Commission (EU) approved Avastin in combination with standard chemotherapy for the treatment of adult patients with carcinoma of the cervix.
Bristol-Myers Squibb has announced that it has completed its acquisition of Flexus Biosciences, Inc.
Pfizer, Inc. is supporting research projects investigating the role of Proprotein Convertase Subtilisin Kexin type 9 (PCSK9) in health and cardiovascular disease.
In a deal that would combine two generic drugmakers that recently left the U.S. for Europe, Mylan says it wants to buy Perrigo for $205 per share, or $28.86 billion.
The company that manufactures the birth control medication Alesse is giving Shoppers Drug Mart credit for alerting the public that expired pills had been dispensed in the last few weeks.
A commonly prescribed antidepressant caused up to a six-fold increase in atherosclerosis plaque in the coronary arteries of non-human primates.
Viagra and other related drugs are not a universal 'cure-all' for impotence, according to a new study from The University of Manchester.
Shares of Arena Pharmaceuticals rose Tuesday after the drug developer said it received an additional patent for its weight loss drug Belviq.
Arvinas announced a strategic collaboration with Merck with the goal of creating novel therapeutics based on protein degradation.
- Page 1